News Releases Investor Relations Investor Menu Overview Events & Presentations Upcoming Events Past Events Presentations Stock Info Stock Quote & Chart Historic Price Lookup Investment Calculator News Releases SEC Filings Analyst Coverage Governance Documents & Charters Committee Composition IR Resources Investor FAQs Email Alerts Contact IR News Releases Year: All News20182017 Summary ToggleDova Pharmaceuticals Announces New Drug Application Submission to FDA for Avatrombopag, a Second Generation Thrombopoietin Receptor Agonist September 22, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at 2017 Leerink Partners Rare Disease Roundtable September 20, 2017 View News Release > Summary ToggleDova Pharmaceuticals Reports Second Quarter 2017 Operating and Financial Results August 10, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 10, 2017 August 3, 2017 View News Release > Summary ToggleDova Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering June 28, 2017 View News Release > Pagination First page First Previous page Previous Page 1 Page 2 Page 3 Current page 4
News Releases Year: All News20182017 Summary ToggleDova Pharmaceuticals Announces New Drug Application Submission to FDA for Avatrombopag, a Second Generation Thrombopoietin Receptor Agonist September 22, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at 2017 Leerink Partners Rare Disease Roundtable September 20, 2017 View News Release > Summary ToggleDova Pharmaceuticals Reports Second Quarter 2017 Operating and Financial Results August 10, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 10, 2017 August 3, 2017 View News Release > Summary ToggleDova Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering June 28, 2017 View News Release > Pagination First page First Previous page Previous Page 1 Page 2 Page 3 Current page 4
